CAXTON CORP
CIK 1388551 · Holdings on Dec 31, 2023 · First reported Feb 14, 2024
Top ten holdings
Q4 2023- XERS71.57%
- SVRA8.97%
- RZLT7.07%
- SPY3.39%
- MTEM2.76%
- BRK.B1.99%
- APGE1.11%
- ABVX0.97%
- LXEO0.75%
- HARP0.70%
Share classes counted separately99.28%
Portfolio value by quarter
Top 10 holdings 12
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | XERSXERIS BIOPHARMA HOLDINGS INC View history and evidence | $13.26M | 71.57% | 5.64M shares | — | ↗▾ | |
| 02 | SVRASAVARA INC View history and evidence | $1.66M | 8.97% | 353.44K shares | — | ↗▾ | |
| 03 | RZLTREZOLUTE INCCOM NEW View history and evidence | $1.31M | 7.07% | 1.32M shares | — | ↗▾ | |
| 04 | SPYSS SPDR S&P 500 ETF TRUST-USTR UNIT View history and evidence | $628.14K | 3.39% | 1.32K shares | — | ↗▾ | |
| 05 | MTEMMOLECULAR TEMPLATES INCCOM NEW View history and evidence | $510.51K | 2.76% | 136.87K shares | — | ↗▾ | |
| 06 | BRK.BBERKSHIRE HATHAWAY INC-CL BCL B NEW View history and evidence | $369.29K | 1.99% | 1.03K shares | — | ↗▾ | |
| 07 | APGEAPOGEE THERAPEUTICS INC View history and evidence | $205.44K | 1.11% | 7.35K shares | — | ↗▾ | |
| 08 | ABVXABIVAX SA-ADRSPONSORED ADS View history and evidence | $179.15K | 0.97% | 16.74K shares | — | ↗▾ | |
| 09 | LXEOLEXEO THERAPEUTICS INC View history and evidence | $138.48K | 0.75% | 10.32K shares | — | ↗▾ | |
| 10 | HARPHARPOON THERAPEUTICS INCCOM NEW View history and evidence | $129.29K | 0.70% | 13.18K shares | — | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 2
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| ACRS ACLARIS THERAPEUTICS INC | Non-derivative | — | — | SEC filing ↗ | |
| 28623U101 ELEVATION ONCOLOGY INC | Non-derivative | — | — | SEC filing ↗ |
2 / 2 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1388551 · Period Dec 31, 2023
Data loaded Sep 23, 2026 · First reported Feb 14, 2024
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 18524322
}Take these holdings further.
This page includes 12 of 12 reported holdings. Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 12 of 12 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.
MCP https://api.akkrudata.ai/mcp
akkru_institutional_holdings
{"action":"portfolio","cik":"1388551","quarter":"2023Q4","page_size":100}
akkru_institutional_holdings
{"action":"history","cik":"1388551","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP / CLI documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.